Category: cardiology

In a groundbreaking study published in the Journal of the American College of Cardiology (JACC) Advances, it was revealed that 40% of individuals with type 2 diabetes (T2D) exhibit albuminuria. This highlights the potential benefits of cardiovascular and renoprotective medications for this population. Surprisingly, the remaining 60% with normoalbuminuria still face a significant risk of […]

Greetings, dear readers! Today, we embark on a journey through the cutting-edge realm of outpatient cardiology. Imagine a world where heart health is not just monitored in hospitals but also in the comfort of outpatient clinics. Let’s delve into the advancements and technologies that are propelling this field forward at an exhilarating pace. Exploring the […]

The landscape of cardiology in Ambulatory Surgery Centers (ASCs) is evolving rapidly, positioning itself as one of the most dynamically expanding service lines within this healthcare sector. The growth is fueled by a combination of factors such as regulatory approvals from the Centers for Medicare & Medicaid Services (CMS), the migration of procedures to outpatient […]

The field of cardiology is facing increasing challenges with a rising demand for heart care and growing administrative burdens on physicians. To address these issues, Becker’s engaged with prominent cardiology leaders to gather their perspectives on how to navigate the staffing challenges currently impacting the industry. In response to the question on the crucial steps […]

In the realm of hypertrophic cardiomyopathy (HCM), the quest for effective treatments continues to unfold, with recent focus on mavacamten, a cardiac myosin inhibitor developed by Bristol Myers Squibb. The ODYSSEY-HCM trial, a pivotal phase 3 study, sought to shed light on the potential of mavacamten in patients with nonobstructive HCM. Led by esteemed researchers […]

In a recent update, the American College of Cardiology has emphasized the critical need for adults with heart disease to receive vaccinations against various respiratory illnesses, including COVID-19, RSV, pneumococcal infection, shingles, and influenza. This recommendation is particularly significant as individuals with heart disease are already classified as a high-risk group, irrespective of age. Dr. […]

As the demographic landscape in the United States continues to shift towards an older population, cardiologists are facing new challenges and opportunities in caring for patients with a higher prevalence of frailty, multiple comorbidities, and complex social needs. This trend is driving the adoption of less invasive procedures, the need for faster clearance processes, the […]

Daily physical activity plays a crucial role in reducing the risk of heart disease. While the common goal of achieving 10,000 steps per day has been widely promoted, recent studies suggest that this target may not be based on solid evidence. Research, including a meta-analysis of 31 studies published in The Lancet Public Health, has […]